Skip to main content

Budesonide Suspension for Inhalation Shortage

Last Updated: November 9, 2024
Status: Current

Products Affected - Description
    • Budesonide inhalation suspension, Amneal, 0.25 mg / 2 mL, 5 single-dose ampules per pouch, 6 pouches, 30 count, NDC 00115-1687-74 - discontinued
    • Budesonide inhalation suspension, Amneal, 0.5 mg / 2 mL, 5 single-dose ampules per pouch, 6 pouches, 30 count, NDC 00115-1689-74 - discontinued
    • Budesonide inhalation suspension, Cipla USA, 0.25 mg / 2 mL, single-dose ampules in individual pouches, 30 count, NDC 69097-0318-53
    • Budesonide inhalation suspension, Cipla USA, 0.25 mg / 2 mL, 5 single-dose ampules per pouch, 6 pouches, 30 count, NDC 69097-0318-87
    • Budesonide inhalation suspension, Teva, 0.25 mg / 2 mL, 5 single-dose ampules per pouch, 6 pouches, 30 count, NDC 00093-6815-73
    • Budesonide inhalation suspension, Teva, 0.5 mg / 2 mL, single-dose ampules in individual pouches, 30 count, NDC 00093-6816-55
    • Budesonide inhalation suspension, Teva, 0.5 mg / 2 mL, 5 single-dose ampules per pouch, 6 pouches, 30 count, NDC 00093-6816-73
    • Budesonide inhalation suspension, Teva, 1 mg / 2 mL, 5 single-dose ampules per pouch, 6 pouches, 30 count, NDC 00093-6817-73
Reason for the Shortage
    • Amneal has discontinued budesonide inhalation suspension.
    • AstraZeneca states Pulmicort Respules are available.
    • Cipla did not provide a reason for the shortage.
    • Lupin has budesonide inhalation suspension available.
    • Nephron has budesonide inhalation suspension available.
    • Sandoz did not provide a reason for the shortage.
    • Teva did not provide a reason for the shortage.
Available Products
    • Budesonide inhalation suspension, Cipla USA, 0.5 mg / 2 mL, 5 single-dose ampules per pouch, 6 pouches, 30 count, NDC 69097-0319-87
    • Budesonide inhalation suspension, Cipla USA, 0.5 mg / 2 mL, single-dose ampules in individual pouches, 30 count, NDC 69097-0319-53
    • Budesonide inhalation suspension, Cipla USA, 1 mg / 2 mL, single-dose ampules in individual pouches, 30 count, NDC 69097-0321-53
    • Budesonide inhalation suspension, Cipla USA, 1 mg / 2 mL, 5 single-dose ampules per pouch, 6 pouches, 30 count, NDC 69097-0321-87
    • Budesonide inhalation suspension, Lupin, 0.5 mg / 2 mL, 5 single-dose ampules per pouch, 6 pouches, 30 count, NDC 68180-0984-30
    • Budesonide inhalation suspension, Nephron Pharmaceuticals Corporation, 0.25 mg / 2 mL, single-dose ampules in individual pouches, 30 count, NDC 00487-9601-30
    • Budesonide inhalation suspension, Nephron Pharmaceuticals Corporation, 0.25 mg / 2 mL, 5 single-dose ampules per pouch, 6 pouches, 30 count, NDC 00487-9601-01
    • Budesonide inhalation suspension, Nephron Pharmaceuticals Corporation, 0.5 mg / 2 mL, single-dose ampules in individual pouches, 30 count, NDC 00487-9701-30
    • Budesonide inhalation suspension, Nephron Pharmaceuticals Corporation, 0.5 mg / 2 mL, 5 single-dose ampules per pouch, 6 pouches, 30 count, NDC 00487-9701-01
    • Budesonide inhalation suspension, Teva, 0.25 mg / 2 mL, single-dose ampules in individual pouches, 30 count, NDC 00093-6815-55

Estimated Resupply Dates

    • Cipla has budesonide 0.25 mg/2 mL (5 vials per pouch) and 0.25 mg/2 mL (30 vials individually packaged) on back order and the company cannot estimate a release date.
    • Sandoz has all budesonide inhalation suspension presentations temporarily unavailable.
    • Teva has most budesonide inhalation suspension presentations on intermittent back order and the company is releasing supplies as they become available.

Updated

Updated November 9, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created May 30, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer